The Geneva Foundation (Geneva), a nonprofit leader in advancing military medicine, today announced the opening of its new office in Frederick, Maryland at the Frederick Innovative Technology Center, Inc. (FITCI), in collaboration with the Frederick County Office of Economic Development (FCOED). The location will serve as Geneva’s Frederick-based research management office as the organization continues to deliver medical research solutions to the Department of Defense (DoD).
Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application GERMANTOWN, Md., Jan. 30, 2023 /PRNewswire/ — Deka Biosciences (“Deka”), a biotech company focused on developing novel cytokine therapies to [….]
Kite And Arcellx Close Agreement To Co-Develop And Co-Commercialize Late-Stage Clinical CART-DdBCMA In Multiple Myeloma
SANTA MONICA, Calif. & REDWOOD CITY, Calif.–(BUSINESS WIRE)– Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX), today announced the closing of the companies’ previously announced global strategic collaboration to co-develop and co-commercialize Arcellx’s lead late-stage product candidate, CART-ddBCMA, for the treatment of patients with relapsed or refractory multiple myeloma. Multiple myeloma is an incurable disease for most patients and the need remains for effective, safe and broadly accessible therapies.
Pharmacy Technician Certification Board Relaunches Online Testing Delivery for Certified Pharmacy Technicians
The Pharmacy Technician Certification Board (PTCB) is kicking off 2023 with new opportunities for Certified Pharmacy Technicians (CPhTs) to demonstrate their knowledge and earn advanced and specialty certificates. PTCB is relaunching OnVUE, an online proctored testing platform, allowing PTCB CPhTs to earn advanced credentials more conveniently.
TEDCO, Maryland’s economic engine for technology companies, announced today its partnership with the Maryland Department of Commerce (Maryland Commerce) to expand and enhance the Maryland Defense Technology Commercialization (DefTech) Center. DefTech supports the growth of businesses by helping them leverage the technology, facilities and expertise in the Maryland Department of Defense (DoD) labs.
Catalent Launches New Service for End-to-End Supply Chain Case Management of Cell and Gene Therapies
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the launch of its new Case Management Service, which has been specifically designed to address the unique challenges associated with the safe and timely delivery of advanced therapies to patients by providing professional supply chain oversight from program start to finish.
New TEDCO Study Outlines Critical Steps Needed to Cultivate a Thriving, Inclusive and Growing Innovation Economy
TEDCO, Maryland’s economic engine for technology companies, unveiled a legislatively mandated Maryland Innovation Competitiveness Study—one that could lead to a 5-year, $250 million down payment for an Equitech Growth Fund and the establishment of a major Kirwan-type commission. The new commission would map out an in-depth strategic plan focused on ensuring Maryland becomes a national model for a thriving, inclusive tech sector and innovation economy.
It has been another successful year for PQE Group, a consulting firm in the Life Sciences industry based in Florence (Italy) with 32 offices worldwide. Recently named “Best Managed Company” by Deloitte, the Group closed in 2022 with a +70% in revenues compared to the previous year, thanks to the tremendous growth in the US and other international markets.
Medcura, Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, announces that the U.S. Food and Drug Administration (FDA) has granted the coveted Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat. LifeGel™ is the first and only hemostatic agent to receive Breakthrough Device Designation seeking a new and highly differentiated indication: in surgical procedures (except in ophthalmic and urological) as an adjunctive hemostatic device when control of minimal, mild, and moderate bleeding by conventional procedures is ineffective or impractical. Due to its no-swell properties, LifeGel can be used in surgical procedures where swelling cannot be tolerated.
McBee, Moore & Vanik IP, LLC began in 2016 when partners Susan McBee, C.G. Moore, David Vanik and 12 employees came together to form a new patent law firm with improved client service as the ultimate goal. This year, the firm is celebrating seven years together.